Browsing: dr krishna ella

Bharat Biotech has submitted its security information to the Drugs Controller General of India (DCGI) based on the phase 2/3…

Covaxin received emergency use approval from the Drug. Controller General of India on January 3.Efficacy information of Bharat Biotech’s Covid-19…

BB will nonetheless be expected to present Phase III data—expected amongst March and October. Whether the drug regulator accepts trial…

Dr Krishna Ella who founded Bharat Biotech in 1996 (IE Image)Bharat Biotech’s Covaxin received the Drug Controller General of India…